These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22214214)

  • 21. Molecular dynamics, free energy, and SPR analyses of the interactions between the SH2 domain of Grb2 and ErbB phosphotyrosyl peptides.
    Suenaga A; Hatakeyama M; Ichikawa M; Yu X; Futatsugi N; Narumi T; Fukui K; Terada T; Taiji M; Shirouzu M; Yokoyama S; Konagaya A
    Biochemistry; 2003 May; 42(18):5195-200. PubMed ID: 12731860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic.
    Oishi S; Karki RG; Shi ZD; Worthy KM; Bindu L; Chertov O; Esposito D; Frank P; Gillette WK; Maderia M; Hartley J; Nicklaus MC; Barchi JJ; Fisher RJ; Burke TR
    Bioorg Med Chem; 2005 Apr; 13(7):2431-8. PubMed ID: 15755645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
    de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
    J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of binding energies of SrcSH2-phosphotyrosyl peptides with structure-based prediction using surface area based empirical parameterization.
    Henriques DA; Ladbury JE; Jackson RM
    Protein Sci; 2000 Oct; 9(10):1975-85. PubMed ID: 11106171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.
    Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR
    J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
    Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
    J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure, dynamics, and binding thermodynamics of the v-Src SH2 domain: implications for drug design.
    Taylor JD; Ababou A; Fawaz RR; Hobbs CJ; Williams MA; Ladbury JE
    Proteins; 2008 Dec; 73(4):929-40. PubMed ID: 18536014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain.
    Lou YC; Lung FD; Pai MT; Tzeng SR; Wei SY; Roller PP; Cheng JW
    Arch Biochem Biophys; 1999 Dec; 372(2):309-14. PubMed ID: 10600169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
    Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
    Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal Structures and Thermodynamic Analysis Reveal Distinct Mechanisms of CD28 Phosphopeptide Binding to the Src Homology 2 (SH2) Domains of Three Adaptor Proteins.
    Inaba S; Numoto N; Ogawa S; Morii H; Ikura T; Abe R; Ito N; Oda M
    J Biol Chem; 2017 Jan; 292(3):1052-1060. PubMed ID: 27927989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimics.
    Li P; Zhang M; Long YQ; Peach ML; Liu H; Yang D; Nicklaus M; Roller PP
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2173-7. PubMed ID: 12798329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of site-directed spin labeling for characterizing protein-ligand complexes using simulated restraints.
    Constantine KL
    Biophys J; 2001 Sep; 81(3):1275-84. PubMed ID: 11509344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational energy penalties of protein-bound ligands.
    Boström J; Norrby PO; Liljefors T
    J Comput Aided Mol Des; 1998 Jul; 12(4):383-96. PubMed ID: 9777496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptides.
    Lee K; Zhang M; Liu H; Yang D; Burke TR
    J Med Chem; 2003 Jun; 46(13):2621-30. PubMed ID: 12801226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide.
    Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
    J Mol Biol; 1999 Jun; 289(3):439-45. PubMed ID: 10356320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in structural dynamics of the Grb2 adaptor protein upon binding of phosphotyrosine ligand to its SH2 domain.
    de Mol NJ; Catalina MI; Fischer MJ; Broutin I; Maier CS; Heck AJ
    Biochim Biophys Acta; 2004 Jul; 1700(1):53-64. PubMed ID: 15210125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal carboxyl and tetrazole-containing amides as adjuvants to Grb2 SH2 domain ligand binding.
    Burke TR; Yao ZJ; Gao Y; Wu JX; Zhu X; Luo JH; Guo R; Yang D
    Bioorg Med Chem; 2001 Jun; 9(6):1439-45. PubMed ID: 11408162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.
    Xu RX; Word JM; Davis DG; Rink MJ; Willard DH; Gampe RT
    Biochemistry; 1995 Feb; 34(7):2107-21. PubMed ID: 7532003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.